Markets
← Back to Stocks
PFE
PFIZER INC
Health Care · Pharmaceuticals
$27.40
+0.27%
Vol: 0.4M
Araverus Market Read
Thursday, March 19, 2026
No significant overnight updates for Pfizer despite early-stage study developments
Pfizer declined 0.80% in pre-market to $27.23 and 0.11% in after-hours to $27.30. Recent headlines include advancement of Phase 2 FOURLIGHT-1 study in metastatic breast cancer and early PF-07328948 liver study results. Stock shows minor declines in both after-hours and pre-market sessions compared to previous close with limited overnight catalysts.
Price 50d 200d
Previous Market Reads
2 of 2 days↓
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$155.9B
P/E (TTM)20.1
Forward P/E9.7
Beta0.41
Div Yield630.00%
Prev Close$27.32
RSI (14-Day)
47Neutral
0305070100
52-Week Range
$20.92$27.40$27.94
From High-2.0%
From Low+31.0%
Moving Averages
50d SMA
$26.50+3.4%
200d SMA
$24.65+11.1%
Price above both MAs — bullish structure.
Returns
1W
+2.0%
1M
+0.1%
3M
+9.1%
6M
+17.9%
1Y
+11.7%
YTD
+10.6%
Volume
Today412K
20d Avg39.5M
Ratio0.01x